Cite
HARVARD Citation
Mensà, E. et al. (2018). MiR‐146a‐5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor‐alpha inhibitor adalimumab. British journal of dermatology. pp. 787-789. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mensà, E. et al. (2018). MiR‐146a‐5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor‐alpha inhibitor adalimumab. British journal of dermatology. pp. 787-789. [Online].